Keratinocyte Growth Factor- Hair Serum for the Prevention of Chemotherapy Induced Alopecia
Status:
Recruiting
Trial end date:
2023-11-29
Target enrollment:
Participant gender:
Summary
Primary aim is to provide a preliminary assessment of the efficacy of the investigational
topical formula, KGF-HS, as a prophylactic treatment for chemotherapy induced alopecia.
Hypothesis: KGF-HS will result in less than 50% hair loss by the end of 4 cycles of
chemotherapy. The investigators will evaluate hair loss using the CTCAE (Common Terminology
Criteria for Adverse Events) v4.0 alopecia grading scale.